TA
TLS Advisors’s Ovid Therapeutics OVID Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Hold |
680,967
| – | – | 0.7% | 12 |
|
|
2025
Q1 | $213K | Hold |
680,967
| – | – | 0.48% | 15 |
|
|
2024
Q4 | $636K | Sell |
680,967
-90,564
| -12% | -$84.6K | 1.45% | 11 |
|
|
2024
Q3 | $910K | Sell |
771,531
-353,765
| -31% | -$417K | 1.92% | 11 |
|
|
2024
Q2 | $866K | Sell |
1,125,296
-194,383
| -15% | -$150K | 2.17% | 11 |
|
|
2024
Q1 | $4.03M | Hold |
1,319,679
| – | – | 9.37% | 6 |
|
|
2023
Q4 | $4.25M | Hold |
1,319,679
| – | – | 14.1% | 3 |
|
|
2023
Q3 | $5.07M | Hold |
1,319,679
| – | – | 20.5% | 2 |
|
|
2023
Q2 | $4.33M | Sell |
1,319,679
-60,667
| -4% | -$199K | 18.57% | 2 |
|
|
2023
Q1 | $3.52M | Sell |
1,380,346
-110,188
| -7% | -$281K | 18.08% | 2 |
|
|
2022
Q4 | $2.77M | Buy |
+1,490,534
| New | +$2.77M | 13.66% | 2 |
|